However, high frequency of CD137+ Treg is associated with poor prognosis in lung adenocarcinoma [65] and another report suggests that agnostic antibody to CD137 in gastric cancer has little effect on Tregs [66]. The gene discussed is TNFRSF9; the disease is lung adenocarcinoma.